Thanks @Piton72
I missed the presentation part but was online for some of the Q&A. I will listen to the recording when it becomes available.
Acadia confirmed they are likely to continue with quarterly sales forecasts for now but likely to swap to annual forecasting at some point in 2024.
Patients mainly coming from centres of excellence but Acadia is now starting to see more patents from the community and other referral centres / clinics as they learn more about Daybue. Acadia sounds very positive about sales pipeline.
All sounding positive ....
Acadia, page-75
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.47 |
Change
0.080(0.41%) |
Mkt cap ! $2.486B | |||
| Open | High | Low | Value | Volume |
| $19.58 | $19.85 | $19.23 | $9.536M | 488.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1770 | $19.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.49 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.51 |
Change
0.080 ( 0.62 %) |
||||
| Open | High | Low | Volume | ||
| $19.60 | $19.82 | $19.24 | 217738 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| NEU (ASX) Chart |